Celeste Lay is thrilled to join KSLA as a morning anchor, bringing warmth and a passion for storytelling to ArkLaTex. A native of Tyler, Texas, Celeste graduated from the University of Mississippi ...
Two TROP2-targeting antibody-drug conjugates, Datroway and Trodelvy, have new data suggesting they could become options for previously untreated patients with triple-negative breast cancer (TNBC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback